相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progress against cancer in the Netherlands since the late 1980s: An epidemiological evaluation
Henrike E. Karim-Kos et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Novel diagnostic biomarkers for prostate cancer
Chikezie O. Madu et al.
Journal of Cancer (2012)
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The prostate cancer screening results in context
Christine D. Berg
ACTA ONCOLOGICA (2011)
Surveillance and Monitoring of Adult Cancer Survivors
Minsig Choi et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Prostate cancer mortality in Taiwanese men: Increasing age-standardized trend in general population and increased risk in diabetic men
Chin-Hsiao Tseng
ANNALS OF MEDICINE (2011)
Role of Functional Polymorphisms of P53 and P73 Genes with the Risk of Prostate Cancer in a Case-Control Study from Northern India
Rama Devi Mittal et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making
Lionne D. F. Venderbos et al.
ASIAN JOURNAL OF ANDROLOGY (2011)
Prostate cancer: an emerging threat to the health of aging men in Asia
Ling Zhang et al.
ASIAN JOURNAL OF ANDROLOGY (2011)
A review of African American-white differences in risk factors for cancer: prostate cancer
Irina Mordukhovich et al.
CANCER CAUSES & CONTROL (2011)
Disruptive Events in the Life of Prostate Cancer
J. Chad Brenner et al.
CANCER CELL (2011)
Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
J. Chad Brenner et al.
CANCER CELL (2011)
A miRNA expression signature that separates between normal and malignant prostate tissues
Jessica Carlsson et al.
CANCER CELL INTERNATIONAL (2011)
Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent
Bao-Li Chang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
A Systematic Review of Replication Studies of Prostate Cancer Susceptibility Genetic Variants in High-Risk Men Originally Identified from Genome-Wide Association Studies
Miriam B. Ishak et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer
Sun Jung Kim et al.
CANCER LETTERS (2011)
MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer
Yi Chen et al.
CANCER PREVENTION RESEARCH (2011)
EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling
Yong-June Kim et al.
CLINICAL CANCER RESEARCH (2011)
Circulating Tumor Cells as Biomarkers in Prostate Cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2011)
Trends in cancer mortality in Mexico, 1981-2007
Cristina Bosetti et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Carmen Jeronimo et al.
EUROPEAN UROLOGY (2011)
Exosomes as Biomarker Treasure Chests for Prostate Cancer
Diederick Duijvesz et al.
EUROPEAN UROLOGY (2011)
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors
Christiane M. Robbins et al.
GENOME RESEARCH (2011)
Hepsin immunohistochemical expression in prostate cancer in relation to Gleason's grade and serum prostate specific antigen
Madhu Mati Goel et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2011)
Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Jeffrey J. Tosoian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Zsofia Kote-Jarai et al.
NATURE GENETICS (2011)
Early Prostate Cancer — Treat or Watch?
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of Consumption of Vegetable, Fruit, Grain, and High Glycemic Index Foods on Aggressive Prostate Cancer Risk
Jill Hardin et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2011)
Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer
Christopher S. Choo et al.
NUTRITION RESEARCH (2011)
P53 Codon 72 (Arg72Pro) Polymorphism and Prostate Cancer Risk: Association between Disease Onset and Proline Genotype
Anja Rogler et al.
PATHOBIOLOGY (2011)
Identification of miRs-143 and-145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT
Xinsheng Peng et al.
PLOS ONE (2011)
Blood Magnesium, and the Interaction with Calcium, on the Risk of High-Grade Prostate Cancer
Qi Dai et al.
PLOS ONE (2011)
GWAS SNP Replication Among African American and European American Men in the North Carolina-Louisiana Prostate Cancer Project (PCaP)
Zongli Xu et al.
PROSTATE (2011)
Disparities at Presentation, Diagnosis, Treatment, and Survival in African American Men, Affected by Prostate Cancer
Ganna Chornokur et al.
PROSTATE (2011)
Use of socio-economic factors and healthcare resources to estimate cancer survival in European countries with partial national cancer registration
Roberto Lillini et al.
TUMORI JOURNAL (2011)
Prostate Cancer and Vitamin D: What Does the Evidence Really Suggest?
Christine M. Barnett et al.
UROLOGIC CLINICS OF NORTH AMERICA (2011)
Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans
Christopher A. Haiman et al.
PLOS GENETICS (2011)
Matrix-Dependent Regulation of AKT in Hepsin-Overexpressing PC3 Prostate Cancer Cells
Stephanie M. Wittig-Blaich et al.
NEOPLASIA (2011)
Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol
Nigel P. Murray et al.
INDIAN JOURNAL OF UROLOGY (2011)
Randomised prostate cancer screening trial: 20 year follow-up
Gabriel Sandblom et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Disease insight and treatment perception of men on active surveillance for early prostate cancer
Roderick C. N. van den Bergh et al.
BJU INTERNATIONAL (2010)
Methylated genes as potential biomarkers in prostate cancer
Veronique Phe et al.
BJU INTERNATIONAL (2010)
Other biomarkers for detecting prostate cancer
Lucas Nogueira et al.
BJU INTERNATIONAL (2010)
The functional significance of microRNA-145 in prostate cancer
M. S. Zaman et al.
BRITISH JOURNAL OF CANCER (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
MicroRNA-205-Directed Transcriptional Activation of Tumor Suppressor Genes in Prostate Cancer
Shahana Majid et al.
CANCER (2010)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Ahmedin Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Lifestyle as risk factor for cancer: Evidence from human studies
Naghma Khan et al.
CANCER LETTERS (2010)
SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation
Martin K. Thomsen et al.
CANCER RESEARCH (2010)
Innovative biomarkers for prostate cancer early diagnosis and progression
Jingjing You et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
State of the epidemiological evidence on physical activity and cancer prevention
Christine M. Friedenreich et al.
EUROPEAN JOURNAL OF CANCER (2010)
Development of a Diagnostic Microarray Assay to Assess the Risk of Recurrence of Prostate Cancer Based on PITX2 DNA Methylation
Philipp Schatz et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer
Amjad P. Khan et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
The epigenome as a therapeutic target in prostate cancer
Antoinette S. Perry et al.
NATURE REVIEWS UROLOGY (2010)
Selenium as a chemoprotective anti-cancer agent: Reality or wishful thinking?
L. Novotny et al.
NEOPLASMA (2010)
Glycan Characterization of PSA 2-DE Subforms from Serum and Seminal Plasma
Ariadna Sarrats et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2010)
Vitamin D Pathway Gene Variants and Prostate Cancer Prognosis
Sarah K. Holt et al.
PROSTATE (2010)
Serum markers of apoptosis decrease with age and cancer stage
Nilay Kavathia et al.
AGING-US (2009)
Association between serum 25(OH) D and death from prostate cancer
S. Tretli et al.
BRITISH JOURNAL OF CANCER (2009)
Diagnostic potential in prostate cancer of a panel of urinary molecular tumor markers
Vincenzo N. Talesa et al.
CANCER BIOMARKERS (2009)
CXC Receptor-1 Silencing Inhibits Androgen-Independent Prostate Cancer
Nagarajarao Shamaladevi et al.
CANCER RESEARCH (2009)
Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2009)
Zinc and prostatic cancer
Emily Ho et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
DNA methylation and aberrant expression of Sprouty1 in human prostate cancer
Bernard Kwabi-Addo et al.
EPIGENETICS (2009)
Biomarkers for Prostate Cancer
Eddy S. Leman et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Scientific Documentation of the Relationship of Vitamin D Deficiency and the Development of Cancer
Richard F. Edlich et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2009)
Epigenetic mechanisms in the biology of prostate cancer
Wolfgang A. Schulz et al.
SEMINARS IN CANCER BIOLOGY (2009)
Fusion in the ETS gene family and prostate cancer
S. A. Narod et al.
BRITISH JOURNAL OF CANCER (2008)
Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
Stefan Ambs et al.
CANCER RESEARCH (2008)
Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
Girish Sardana et al.
CLINICAL CHEMISTRY (2008)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase
David Robinson et al.
JOURNAL OF UROLOGY (2008)
Prevalence of incidental prostate cancer in the general population: A study of healthy organ donors
Ming Yin et al.
JOURNAL OF UROLOGY (2008)
PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer
David Robinson et al.
UROLOGY (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Widespread deregulation of microRNA expression in human prostate cancer
M. Ozen et al.
ONCOGENE (2008)
Biomarkers for prostate cancer detection
Dipen J. Parekh et al.
JOURNAL OF UROLOGY (2007)
Targeted treatment of prostate cancer
Xinning Warg et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Assessment of 54 biomarkers for biopsy-detectable prostate cancer
Dipen J. Parekh et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
MicroRNA expression profiling in prostate cancer
Kati P. Porkka et al.
CANCER RESEARCH (2007)
A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer
Eric Richter et al.
EPIGENETICS (2007)
CD44 and PTGS2 Methylation are Independent Prognostic Markers for Biochemical Recurrence Among Prostate Cancer Patients with Clinically Localized Disease
Karen Woodson et al.
EPIGENETICS (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Pancreatic cancer epidemiology
M Verma
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Opinion - Rules of evidence for cancer molecular-marker discovery and validation
DF Ransohoff
NATURE REVIEWS CANCER (2004)
Research issues and strategies for genomic and proteomic biornarker discovery and validation: a statistical perspective
Z Feng et al.
PHARMACOGENOMICS (2004)
Serum protein expression profiling for cancer detection: Validation of a SELDI-based approach for prostate cancer
WE Grizzle et al.
DISEASE MARKERS (2003)
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood
R Rosenberg et al.
CYTOMETRY (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
分享论文
